Skip to main content

Recombinant Proteins in Vaccine Development

  • Protocol

Part of the Methods in Molecular Medicine™ book series (MIMM,volume 66)

Abstract

The outer membrane of Neisseria meningitidis contains a variety of proteins with the potential for inclusion in new meningococcal vaccines (1). Studies on the vaccine potential of these proteins would be facilitated by the production of pure recombinant protein, free from other components of the Neisseria outer membrane. At present, the class 1 outer-membrane protein (OMP) is generally regarded as the most promising candidate. In this chapter, we describe four protocols involved in the preparation of recombinant class 1 OMP for vaccine development. This integrated set of methods can also be readily used to study the potential of other meningococcal OMP as vaccine candidates, and moreover, their utilities make them attractive for vaccine studies relating to many other human pathogens.

Keywords

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Poolman, J. T., van der Ley, P. A., and Tommassen, J. (1995) Surface structures and secreted products of meningococci, in Meningococcal Disease (Cartwright, K. A. V., ed.), John Wiley and Sons, Chichester, UK, pp. 21–34.

    Google Scholar 

  2. Barlow, A. K., Heckels, J. E., and Clarke, I. N. (1987) Molecular cloning and expression of Neisseria meningitidis class 1 outer membrane protein in Escherichia coli K12. Infect. Immun. 55, 2734–2740.

    CAS  PubMed  Google Scholar 

  3. Barlow, A. K., Heckels, J. E., and Clarke, I. N. (1989) The class 1 outer membrane protein of Neisseria meningitidis: gene sequence and structural and immunological similarities to gonococcal porins. Mol. Microbiol. 3, 131–139.

    Article  CAS  PubMed  Google Scholar 

  4. White, D. A., Barlow, A. K., Clarke, I. N., and Heckels, J. E. (1990) Stable expression of meningococcal class 1 protein in an antigenically reactive form in outer membranes of Escherichia coli. Mol. Microbiol. 4, 769–776.

    Article  CAS  PubMed  Google Scholar 

  5. Nurminen, M., Butcher, S., Idanpaan-Heikkila, I., Wahlstrom, E., Muttilainen, S., Runeberg-Nyman, K., et al. (1992) The class 1 outer membrane protein of Neisseria meningitidis produced in Bacillus subtilis can give rise to protective immunity. Mol. Microbiol. 6, 2499–2506.

    Article  CAS  PubMed  Google Scholar 

  6. Muttilainen, S., Idanpaan-Heikkila, I., Wahlstrom, E., Nurminen, M., Makela, P. H., and Sarvas, M. (1995) The Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis and reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes. Microb. Pathog. 18, 423–436.

    Article  CAS  PubMed  Google Scholar 

  7. Muttilainen, S., Butcher, S. J., Runeberg, K., Nurminen, M., Idanpaan-Heikkila, I., Wahlstrom, E., and Sarvas, M. (1995) Heterologous production of the P1 porin of Neisseria meningitidis in Bacillus subtilis: the effect of an N-terminal extension on the presentation of native-like epitopes. Microb. Pathog. 18, 365–371.

    Article  CAS  PubMed  Google Scholar 

  8. Ward, S. J., Scopes, D. A., Christodoulides, M., Clarke, I. N., and Heckels, J. E. (1996) Expression of Neisseria meningitidis class 1 porin as a fusion protein in Escherichia coli: the influence of liposomes and adjuvants on the production of a bactericidal immune response. Microb. Pathog. 21, 499–512.

    Article  CAS  PubMed  Google Scholar 

  9. QIAGEN (1997) The QIAexpressionist. A handbook for high-level expression and purification of 6xHis-tagged proteins.

    Google Scholar 

  10. Christodoulides, M., Brooks, J. L., Rattue, E., and Heckels, J. E. (1998) Immunisation with recombinant class 1 outer membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci. Microbiology 144, 3027–3037.

    Article  CAS  PubMed  Google Scholar 

  11. Gregoriadis, G. (1995) Liposomes as immunological adjuvants, in The Theory and Practical Application of Adjuvants (Stewart-Tull, D. E. S., ed.), John Wiley and Sons Ltd., Chichester, UK, pp. 145–169.

    Google Scholar 

  12. Tinsley, C. R. and Heckels, J. E. (1986) Variation in the expression of pili and outer membrane protein by Neisseria meningitidis during the course of meningococcal infection. J. Gen. Microbiol. 132, 2483–2490.

    CAS  PubMed  Google Scholar 

  13. Ausebel, F. M., Brent, R., Kingston, R. E., Moore, D. D, Sedman, J. G, Smith, J. A, and Struhl, K. (1995) Current Protocols in Molecular Biology, John Wiley and Sons, New York.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Christodoulides, M., Jolley, K.A., Heckels, J.E. (2001). Recombinant Proteins in Vaccine Development. In: Pollard, A.J., Maiden, M.C. (eds) Meningococcal Vaccines. Methods in Molecular Medicine™, vol 66. Humana Press. https://doi.org/10.1385/1-59259-148-5:167

Download citation

  • DOI: https://doi.org/10.1385/1-59259-148-5:167

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-801-1

  • Online ISBN: 978-1-59259-148-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics